Pfizer booster shot (teachers)

The FDA instead limited its authorization of the third Pfizer dose to
people 65 and older,
people ages 18-64 at high risk of severe COVID-19 due to pre-existing conditions, and
individuals with frequent risk of exposure to the coronavirus through their work, such as
    health care workers and 

    teachers. 

 

“As CDC Director, it is my job to recognize where our actions can have the greatest impact. At CDC, we are tasked with analyzing complex, often imperfect data to make concrete recommendations that optimize health. In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good,” Walensky said in a statement.